 |
인쇄하기
취소
|
BMS seeks health insurance allowance for new antitumor agent
BMS Korea says it plans to negotiate with the Ministry of Health and Welfare over the insurance price of its Sprycel (dasatinib), an oral inhibitor of multiple tyrosine kinases.
The company failed to reach an agreement with the National Health Insurance Corporation on the insurance price of Sprycel.
Under the new drug pricing policy, the Health Insurance Review Agency will form a committe...
The company failed to reach an agreement with the National Health Insurance Corporation on the insurance price of Sprycel.
Under the new drug pricing policy, the Health Insurance Review Agency will form a committe...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.